European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis

AbbVie passes US FDA approval for RINVOQ for treating moderate to severe Rheumatoid Arthritis (RA)

The United States Food and Drug Administration grants approval to AbbVie's rheumatoid arthritis drug RINVOQ

Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi 

Landos Biopharma Completes USD 60m Series B Financing

Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic

Immunovant names new chief medical officer

Calliditas announces exclusive in-licensing related to autoimmune hepatitis in the US market

Rewind Therapeutics announces EUR2.9m VLAIO grant for developing new drug candidates for myelin-related neurological diseases

FDA Approves New Monotherapy Indication for Merck's Keytruda

Alexion Receives Positive CHMP Opinion for SOLIRIS (eculizumab) for the Treatment of NMOSD

Alvotech signs commercialisation contract with Cipla Gulf FZ

Banner Life Sciences Enrolls First Subject in Randomised, Double-Blind Head-to-Head Study of Bafiertam and Tecfidera for Comparative Assessment of GI Tolerability

Saniona plans development of preclinical candidate SAN903 to phase 1 clinical study in 18 months

Immunocore and Pulse Infoframe Partner with Academic Institutions to Launch First Global Patient Registry for Uveal Melanoma